Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jul
18
2023
China’s Utility Model Grants Down 25% in First Half of 2023; Invention Patent Grants Up 10% Schwegman, Lundberg & Woessner, P.A.
Feb
15
2016
IPRs And Settlement of Patent Infringement Cases Schwegman, Lundberg & Woessner, P.A.
Sep
9
2013
Divided Federal Circuit Panel Finds Computer System Claims Not Patent-Eligible Schwegman, Lundberg & Woessner, P.A.
Sep
13
2013
Software Entrepreneur Calls New Zealand’s Software Ban ‘Worst Advice in History of Capitalism’ Schwegman, Lundberg & Woessner, P.A.
Apr
18
2019
Senate Committee Releases Outline for Section 101 Reform Schwegman, Lundberg & Woessner, P.A.
Nov
28
2023
China’s National Intellectual Property Administration: “Swing Your Sword and Punch Hard!” China Cracks Down on Fake Patent Agents Schwegman, Lundberg & Woessner, P.A.
Dec
21
2023
China’s State Council Releases Amended Implementing Regulations of the Patent Law Schwegman, Lundberg & Woessner, P.A.
Jan
28
2024
China’s Supreme People’s Court Upholds 201.54 Million RMB Trade Secret Verdict Schwegman, Lundberg & Woessner, P.A.
Mar
6
2014
Patent and Trademark Office (PTO) Releases Guidelines On Patenting “Natural Phenomena And Natural Products” Schwegman, Lundberg & Woessner, P.A.
Sep
16
2019
Senate Subcommittee on IP Holds Hearings on SWOT of STRONGER Bill Schwegman, Lundberg & Woessner, P.A.
Nov
8
2019
Hong Kong, PRC Launches New Patent System Effective December 19, 2019 Schwegman, Lundberg & Woessner, P.A.
Nov
28
2019
Utility Model Patents: An Overlooked Chinese IP Right Schwegman, Lundberg & Woessner, P.A.
Dec
10
2019
Solicitor General’s Briefs Encourage Supreme Court to Put s. 101 Back on Track Schwegman, Lundberg & Woessner, P.A.
Apr
10
2024
3.5-Year Prison Sentence for Counterfeiting Maotai, the National Drink of China Schwegman, Lundberg & Woessner, P.A.
Jun
21
2016
Same-Day Continuing Patent Applications are Co-pending under s. 120 Schwegman, Lundberg & Woessner, P.A.
Apr
17
2024
China’s Securities Regulatory Commission Proposes Increasing Patent Requirement for IPOs Schwegman, Lundberg & Woessner, P.A.
Feb
6
2020
Wuhan Institute of Virology Applies for a Patent on Gilead’s Remdesivir Schwegman, Lundberg & Woessner, P.A.
Mar
4
2020
China Waives Late Fees for Missed Patent Annuities due to Coronavirus Schwegman, Lundberg & Woessner, P.A.
Mar
27
2020
China’s State Administration of Market Regulation Releases 2020 Legislative Plan Schwegman, Lundberg & Woessner, P.A.
Sep
26
2016
Vanda v. Roxane Labs. – Are Two Natural Laws Better Than One? Schwegman, Lundberg & Woessner, P.A.
Apr
27
2020
Patent Strategies For Expedited Chinese Approval Of Medical Devices Schwegman, Lundberg & Woessner, P.A.
Jul
18
2014
Digitech Image Technologies, LLC v. Electronics For Imaging, Inc. — Data Structures Per Se Not Patentable Schwegman, Lundberg & Woessner, P.A.
May
20
2020
China’s Upsurge in Patent Filings Continue Post-Coronavirus Lockdown Schwegman, Lundberg & Woessner, P.A.
Jun
1
2020
China’s New Civil Law Includes Technology Transfer and Development Articles Schwegman, Lundberg & Woessner, P.A.
Jul
13
2020
Latest Decision by Supreme People’s Court Of China Confirms Validity of “Little i Robot” Patent in Blow to Apple Schwegman, Lundberg & Woessner, P.A.
Jul
27
2020
Dana-Farber v. Ono – Co-Inventorship Rules Schwegman, Lundberg & Woessner, P.A.
Aug
1
2020
China’s Patent Office Invalidates Chinese Shoe Design Patent Using the ASICS Stripes Trademark Schwegman, Lundberg & Woessner, P.A.
Feb
13
2017
PTAB Narrows Its Preliminary Claim Interpretation To Uphold Cellular Patent Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins